FDA Registration of the Lab — Ensures timely inspections and quality adherence at the place of manufacture.
Assess…Repair…Maintain
The Genesis Regenerative Roadmap To Health
Genesis Regenerative is proud to support 15+ clinical specialties that are actively utilizing our products in over 70+ healthcare concerns. Our prestigious Medical Directors and Clinical Advisory Board have been ongoingly educating Genesis that their clinical outcomes have been enhanced, and are more durable, when advanced diagnostic testing and support therapies are utilized in conjunction with regenerative therapies.
Following the guidance of our nationally and internationally renowned medical leadership, Genesis is launching the “Roadmap to Health” that combines genomic testing (PGX / NGX), advanced regenerative therapies (RPA / MUSE RPA), and adjunct therapies that fit into everyday life (Push Patch). Please see the information below to learn more, and ask your treating clinician if utilizing the Genesis Roadmap to Health might benefit in creating a more customized healthcare plan for you and your family.
Genomics testing that provides deep dive insight into prescription, diet, exercise, environmental factors, mental health impact of inherited genes, allowing for a more customized treatment plan.
320+ Verified healing proteins from the endoderm (soft tissue/organ), mesoderm (MSK), and ectoderm (brain / nerve), providing the “active ingredients” of MSC’s / Exosomes, without the cellular and DNA transfer risk.
Transdermal, needle-free delivery of therapeutics like NAD+ and peptides that provide time-sequential release and greater bioavailability.
How To Be A Smart Regenerative Medicine Consumer
Three Generations, One Direction
Regenerative medicine has moved through three general phases. Each generation of therapies has advanced science but also comes with its own trade-offs. This is exactly why learning the therapies in a head-to-head comparison will allow you to be a more educated consumer.
Generation 1
First came autologous blood concentrates (like PRP), drawn from a patient’s own blood, however effectiveness is only as much as the patient’s age and health allow.
Generation 2
Next came live stem cell approaches, introducing donor cellular material, which is effective but holds risk of a negative immune response.
Generation 3
Most recently, research has shifted toward acellular, protein-based signaling therapies — delivering the biological messengers directly, without introducing live cells or DNA into the body at all.
AT A GLANCE
How the Options Compare
| Property | PRP | Stem Cells | Exosomes | Genesis RPA |
|---|---|---|---|---|
| Source | Patient’s own blood | Donor cells | Lab-cultured cell byproduct | Ethically sourced placental tissue |
| Live cells / Contains DNA | Yes (Patient-derived) | Yes (Donor-derived) | No | No |
| 3rd-Party Verified Protein Contents | No (Patient-dependent) | No (Origin-dependent) | No (Origin-dependent) | 300+ verified proteins |
| Outcome consistency | Varies by age/health | Varies by origin | Varies by origin | Standardized per batch |
SMART CONSUMER CHECKLIST
How to Be a Smart Consumer
Whether you’re speaking with your clinician, researching a therapy, or looking into a lab that produces a product, there’s documentation every legitimate source should be able to provide:
Note: Product that can’t produce this documentation should be approached with caution, not necessarily ruled out, but further discussion with your provider is recommended.
Ready to See the Documentation for Yourself?
Send a few details and a Genesis-affiliated team member will follow up — no purchase, no commitment.